96 related articles for article (PubMed ID: 22974608)
21. Developmental markers of ganglion cells in the enteric nervous system and their application for evaluation of Hirschsprung disease.
Kawai H; Satomi K; Morishita Y; Murata Y; Sugano M; Nakano N; Noguchi M
Pathol Int; 2014 Sep; 64(9):432-42. PubMed ID: 25146344
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of RET-induced Hirschsprung pathogenesis.
Lantieri F; Griseri P; Ceccherini I
Ann Med; 2006; 38(1):11-9. PubMed ID: 16448984
[TBL] [Abstract][Full Text] [Related]
23. A common haplotype at the 5' end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression.
Griseri P; Bachetti T; Puppo F; Lantieri F; Ravazzolo R; Devoto M; Ceccherini I
Hum Mutat; 2005 Feb; 25(2):189-95. PubMed ID: 15643606
[TBL] [Abstract][Full Text] [Related]
24. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
Zhao W; Shen Y; Ren S
Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
[TBL] [Abstract][Full Text] [Related]
25. Association analysis of the PHOX2B gene with Hirschsprung disease in the Han Chinese population of Southeastern China.
Liu CP; Li XG; Lou JT; Xue Y; Luo CF; Zhou XW; Chen F; Li X; Li M; Li JC
J Pediatr Surg; 2009 Sep; 44(9):1805-11. PubMed ID: 19735829
[TBL] [Abstract][Full Text] [Related]
26. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
27. Promotion of spermatogonial proliferation by neuregulin 1 in newt (Cynops pyrrhogaster) testis.
Oral O; Uchida I; Eto K; Nakayama Y; Nishimura O; Hirao Y; Ueda J; Tarui H; Agata K; Abé S
Mech Dev; 2008; 125(9-10):906-17. PubMed ID: 18586089
[TBL] [Abstract][Full Text] [Related]
28. Differential expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung disease.
Wang W; Su Z; Chen D; Mi J; Gao H
Int J Clin Exp Pathol; 2014; 7(5):2312-8. PubMed ID: 24966941
[TBL] [Abstract][Full Text] [Related]
29. Demethylation of GFRA4 Promotes Cell Proliferation and Invasion in Hirschsprung Disease.
Wang G; Zhang L; Wang H; Cui M; Liu W; Liu Y; Wu X
DNA Cell Biol; 2018 Apr; 37(4):316-324. PubMed ID: 29634418
[TBL] [Abstract][Full Text] [Related]
30. Long none coding RNA HOTTIP/HOXA13 act as synergistic role by decreasing cell migration and proliferation in Hirschsprung disease.
Xie H; Zhu D; Xu C; Zhu H; Chen P; Li H; Liu X; Xia Y; Tang W
Biochem Biophys Res Commun; 2015 Aug; 463(4):569-74. PubMed ID: 26043692
[TBL] [Abstract][Full Text] [Related]
31. Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease.
Tang W; Qin J; Tang J; Zhang H; Zhou Z; Li B; Geng Q; Wu W; Xia Y; Xu X
Cell Physiol Biochem; 2013; 32(6):1655-67. PubMed ID: 24334875
[TBL] [Abstract][Full Text] [Related]
32. Study of the effect of miR‑124 and the SOX9 target gene in Hirschsprung's disease.
Mi J; Chen D; Wu M; Wang W; Gao H
Mol Med Rep; 2014 May; 9(5):1839-43. PubMed ID: 24604230
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of endothelin-B receptor gene in patients with Hirschsprung disease in Taiwan.
Lin YC; Lai HS; Hsu WM; Lee PI; Chen HL; Chang MH
J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):36-40. PubMed ID: 18162831
[TBL] [Abstract][Full Text] [Related]
34. Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.
Burzynski GM; Nolte IM; Osinga J; Ceccherini I; Twigt B; Maas S; Brooks A; Verheij J; Plaza Menacho I; Buys CH; Hofstra RM
Eur J Hum Genet; 2004 Aug; 12(8):604-12. PubMed ID: 15138456
[TBL] [Abstract][Full Text] [Related]
35. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
36. [Association of single nucleotide polymorphisms of Axis inhibitor-2 gene rs224030, rs8081536, rs9913621 with Hirschsprung disease].
Gao H; Zhang J; Wang W; Zhang Z; Huang Y; Zhang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):697-700. PubMed ID: 19065536
[TBL] [Abstract][Full Text] [Related]
37. Comparative proteomic profiles of the normal and aganglionic hindgut in human Hirschsprung disease.
Zhang SC; Chen F; Jiang KL; Yuan ZW; Wang WL
Pediatr Res; 2014 Jun; 75(6):754-61. PubMed ID: 24608570
[TBL] [Abstract][Full Text] [Related]
38. The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprung's disease.
Moore SW; Sidler D; Zaahl MG
J Pediatr Surg; 2008 Aug; 43(8):1439-44. PubMed ID: 18675632
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the genes encoding the 4 RET ligands, GDNF, NTN, ARTN, PSPN, and susceptibility to Hirschsprung disease.
Fernandez RM; Ruiz-Ferrer M; Lopez-Alonso M; Antiñolo G; Borrego S
J Pediatr Surg; 2008 Nov; 43(11):2042-7. PubMed ID: 18970938
[TBL] [Abstract][Full Text] [Related]
40. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
